Navigation Links
Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
Date:8/24/2007

PALO ALTO, Calif., Aug. 24 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that Mark A. Tarnopolsky, MD, PhD, FRCPC, professor at McMaster University in Hamilton, Ontario, Canada, presented a summary of findings demonstrating the positive effect of energy enhancing compounds for the potential treatment of neuromuscular diseases.

The findings were presented at the 10th International Congress on Amino Acids and Proteins (ICAAP) in Kallithea, Chalkidiki, Greece and is part of an ongoing collaborative program with Avicena to identify energy enhancing molecules as potential therapeutic agents for applications in neuromuscular diseases.

ABOUT AVICENA

Avicena Group, Inc. (OTC Bulletin Board: AVGO) is a Palo Alto, California based late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases. The company's core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena's pharmaceutical program centers on rare neurological disorders (orphan diseases). The company is currently analyzing data from its Phase IIb/III trial in ALS. Near term, Avicena intends to initiate a Phase III trial in Huntington's disease to accompany the ongoing NIH Phase III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

SAFE HARBOR

This release contains forward-looking statements that reflect, among other things, management's current expectations, plans and strategies, all of which
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
2. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
3. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
6. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
7. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
8. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
9. Inspire Announces Presentations at Two European Scientific Conferences
10. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
11. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... Monitoring & Cardiac Rhythm Management Market ECG, Implantable ... Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, ... MarketsandMarkets, the global Cardiac Monitoring (CM) and Cardiac ... reach $26,646.5 Million by 2020 from $21,137.7 Million ...
(Date:7/3/2015)... , July 3, 2015 A ... of hypertension, diabetes and thyroid disorders in ... and a major conference dedicated to these diseases. ... Diabetes Online , Manage Hypertension Online and ... operated by EXCEMED - combine the world,s ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the ... an online service for the management of data on ... today that PharmaShine now includes the 2014 Open Payments ... Medicare Services on June 30. The data disclosed on ... transactions between industry and providers totaling $6.49 billion and ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... BRUSSELS, August 31, 2011 Research into blood-related ... citizens each year, but lack of awareness of this fact ... into advancing the treatment of patients. "Haematology is ... in recent years," said Professor Robin Foà of "La Sapienza" ...
... RIVER, Mass., Aug. 31, 2011 Millstone Medical ... Neuberger as Vice President of Operations of the ... manufacturing executive, will have overall responsibility for managing ... kit processing and distribution, a core function of ...
Cached Medicine Technology:Better Funding for Research into Blood Diseases Will Save More Lives 2Millstone Medical Outsourcing Hires Seasoned VP of Operations to Run Memphis Facility 2
(Date:7/5/2015)... ... July 05, 2015 , ... ... the Weed Master, a landscaping invention that effectively removes weeds without harming ... dollars," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It ...
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in ... results of an annual member survey , detailing the most common plastic surgery ... group broke that raw data down into charts detailing demographic trends and regional ...
(Date:7/3/2015)... ... ... will hopefully be getting a large donation of canned food items at the end ... making it their mission to collect as many canned items as possible. Donations do not ... as well. As part of the canned food drive, these local chiropractors will be donating ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar ... at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar ... points of investigating these types of cases. , Each year, New York State ...
Breaking Medicine News(10 mins):Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... University have successfully produced Plague vaccines from Tobacco plants. ... // plant which is found to be effective against ... The researchers are to start a clinical trial of ... of the new vaccine. The researchers have reported the ...
... undergo a lot of mental strain contracting heart diseases, according ... in blood pressure and brain activity during stress. ... its links to stress and heart disease has been taken ... used functional magnetic resonance imaging (FMRI), a non-invasive technique for ...
... patients who need psychiatric care in the UK are being ... to a massive shortage // of NHS beds. ... crisis management, with patients being sent home at night or ... from the Mental Health Act Commission. ,The team ...
... A research was conducted by Lijing l. Yan, PhD., M.P.H., ... Peking University, China, and colleagues on the effects of overweigh ... // ,The Chicago Heart Association study conducted a ... studied from 31 year of age through 64 years. They ...
... Australian rural doctors who specialize in surgery, obstetrics and ... federal Government just to continue the work they are ... incentives to push general practitioners who carry out procedures ... that will cost taxpayers an extra $5.2million each year. ...
... virus’ signature has not been seen in India so far, ... N.Ganguly // . The institution has also set up with ... are also being kept under surveillance to ensure that the ... ,The normal flu vaccine is also sought to be enhanced, ...
Cached Medicine News:Health News:Tobacco plant based Vaccine against Plague 2Health News:NHS faces mental health crisis; 'risky' patients sent home 2Health News:Obesity Increases The Risk Of Cardiovascular Diseases 2Health News:Specialist rural GPs to get incentive in Australia 2
... The biokitHSV-2 Rapid Test is a single ... in heparinized capillary whole blood taken by ... specific for herpes simplex virus type 2 ... with HSV-2. It is intended for in-vitro ...
... Piccolo is the first compact, broad menu ... testing in any treatment setting. Care givers ... panels with less than one minute of ... comparable in quality to larger, expensive laboratory ...
The GelPort XE hand access system combines the technology of the GelSeal® cap with the retraction and protection of the Alexis wound retractor....
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
Medicine Products: